U.S. drugmaker Eli Lilly said on Monday it will offer the higher-dose versions of its popular weight-loss drug Zepbound on its website LillyDirect, with shipments starting in early August.
The company said the 12.5 milligrams and 15 mg doses of the drug will be available for US$499 per month on the website with shipments to self-paying patients.
- U.S. inflation hits 3-year high with gas prices climbing amid Iran war
- Are headlights too bright? Nearly 380K Canadians told Ottawa their answer
- Interest in ‘The Clifton’ multi-million dollar condos a reflection of Edmonton real estate
- Breakfast brewskies: Alberta bars, restaurants now allowed to serve alcohol at 6 a.m.
Healthcare providers can begin prescribing the 12.5 mg and 15 mg vials on July 7, the company added.
Lilly began offering vials of the two lowest doses of Zepbound, typically sold in auto-injector pens, in August last year.
In February, the company started offering the vials at a discount.
Comments
Want to discuss? Please read our Commenting Policy first.